JW Medical Systems (China)

JW Medical Systems (吉威医疗) is a Chinese enterprise in the interventional medicine field, founded in 2003 in Weihai, Shandong. It researches, develops, produces and sells high-tech interventional medical products. It became part of Biosensors International Group and later a member enterprise of the A-share listed Lanfan Medical. Its product lines include coronary, neuro and peripheral interventional products.

JW Medical Systems was founded in 2003 in Weihai, Shandong, China. It obtained TUV, ISO 9001 and ISO 13485 certifications in 2004, and in 2005 obtained an SFDA medical device registration certificate and launched China's first biodegradable-polymer DES product. In 2011 it was recognized as a high-tech enterprise and its industrial park in Weihai was completed. In 2012 it became a wholly-owned subsidiary in China of Biosensors International, a world top-100 medical enterprise. In 2018 it became a member enterprise of the A-share listed Lanfan Medical. In 2019 its parent Lanfan Medical acquired Swiss heart valve company NVT. In 2020 its parent established a Shanghai R&D center in Zhangjiang Science City. In 2021 its parent invested in a domestic OCT brand and the Biofreedom TM DCS stent was to enter China.

An enterprise integrating multiple innovative solutions and extraordinary achievements in the interventional medicine field, with innovation, trust, professionalism and development as its core competitiveness.

• 柏腾 (BA9 drug-coated coronary balloon catheter)

  China's first limus drug balloon, carrying the latest-generation rapamycin derivative BA9, with high lipophilicity and long-lasting efficacy, using a unique crystallization process and PEO hydrophilic coating.

• 心跃 EXCROSSAL

  New-generation biodegradable polymer coronary stent, officially launched in 2017.

• 爱克塞尔 Excel

  Biodegradable polymer DES product; cumulative sales reached 2 million units by 2018.

1. 1吉威医疗jwmedical.com.cn
2. 2吉威里程碑 - 吉威医疗jwmedical.com.cn
3. 3吉威医疗jwmedical.com.cn
4. 4合作伙伴 - 吉威医疗jwmedical.com.cn